Facultad de Farmacia, Departamento de Química Farmacéutica y Orgánica, Universidad de Granada, Granada, Spain.
Arch Pharm (Weinheim). 2016 Aug;349(8):638-50. doi: 10.1002/ardp.201600020. Epub 2016 Jun 21.
The synthesis of different compounds with a quinazolinone, quinazolinthione, or quinazolinimine skeleton and their in vitro biological evaluation as inhibitors of inducible and neuronal nitric oxide synthase (iNOS and nNOS) isoforms are described. These derivatives were obtained from substituted 2-aminobenzylamines, using diverse cyclization procedures. Furthermore, the diamines were synthesized by two routes: A conventional pathway and an efficient one-pot synthesis in a continuous-flow hydrogenator. The structures of these heterocycles were confirmed by (1) H and (13) C nuclear magnetic resonance and high-resolution mass spectroscopy data. The structure-activity relationships of the target molecules are discussed in terms of the effects of both the R radical and the X heteroatom in the 2-position. In general, the assayed compounds behave as better iNOS than nNOS inhibitors, with the quinazolinone 11e being the most active inhibitor of all tested compounds and the most iNOS/nNOS selective one.
描述了不同化合物的合成,这些化合物具有喹唑啉酮、喹唑啉硫酮或喹唑啉亚胺骨架,其作为诱导型和神经元型一氧化氮合酶(iNOS 和 nNOS)同工酶的抑制剂在体外具有生物活性。这些衍生物是通过取代的 2-氨基苄胺,使用不同的环化程序获得的。此外,二胺通过两种途径合成:常规途径和连续流氢化器中的高效一锅合成。这些杂环的结构通过(1)H 和(13)C 核磁共振和高分辨率质谱数据得到确认。根据 2-位的 R 自由基和 X 杂原子的影响,讨论了目标分子的构效关系。一般来说,所测试的化合物表现出更好的 iNOS 抑制活性,而 nNOS 抑制活性较差,其中喹唑啉酮 11e 是所有测试化合物中最有效的抑制剂,也是最具 iNOS/nNOS 选择性的抑制剂。